{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:09:09Z","timestamp":1794931749868,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1D1A1B07047594"],"award-info":[{"award-number":["NRF-2018R1D1A1B07047594"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To determine the clinical feasibility of novel serum biomarkers in out-of-hospital cardiac arrest (OHCA) patients treated with target temperature management (TTM).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study was a prospective observational study conducted on OHCA patients who underwent TTM. We measured conventional biomarkers, neuron\u2011specific enolase and S100 calcium-binding protein (S-100B), as well as novel biomarkers, including tau protein, neurofilament light chain (NFL), glial fibrillary acidic protein (GFAP), and ubiquitin C-terminal hydrolase-L1 (UCH-L1), at 0, 24, 48, and 72\u00a0h after the return of spontaneous circulation identified by SIMOA immunoassay. The primary outcome was poor neurological outcome at 6\u00a0months after OHCA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 100 patients were included in this study from August 2018 to May 2020. Among the included patients, 46 patients had good neurologic outcomes at 6\u00a0months after OHCA. All conventional and novel serum biomarkers had the ability to discriminate between the good and poor neurological outcome groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The area under the curves of the novel serum biomarkers were highest at 72\u00a0h after cardiac arrest (CA) (0.906 for Tau, 0.946 for NFL, 0.875 for GFAP, and 0.935 for UCH-L1). The NFL at 72\u00a0h after CA had the highest sensitivity (77.1%, 95% CI 59.9\u201389.6) in predicting poor neurological outcomes while maintaining 100% specificity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Novel serum biomarkers reliably predicted poor neurological outcomes for patients with OHCA treated with TTM when life-sustaining therapy was not withdrawn. Cutoffs from two large existing studies (TTM and COMACARE substudy) were externally validated in our study. The predictive power of the novel biomarkers was the highest at 72\u00a0h after CA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-023-04400-1","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:46:01Z","timestamp":1679863561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Novel serum biomarkers for predicting neurological outcomes in postcardiac arrest patients treated with targeted temperature management"],"prefix":"10.1186","volume":"27","author":[{"given":"Hwan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonho","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Nam","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Song","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"issue":"4","key":"4400_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00134-021-06368-4","volume":"47","author":"JP Nolan","year":"2021","unstructured":"Nolan JP, Sandroni C, Bottiger BW, Cariou A, Cronberg T, Friberg H, et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care. Intensive Care Med. 2021;47(4):369\u2013421. https:\/\/doi.org\/10.1007\/s00134-021-06368-4.","journal-title":"Intensive Care Med"},{"issue":"1","key":"4400_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13054-022-03913-5","volume":"26","author":"J Humaloja","year":"2022","unstructured":"Humaloja J, Ashton NJ, Skrifvars MB. Brain injury biomarkers for predicting outcome after cardiac arrest. Crit Care. 2022;26(1):81. https:\/\/doi.org\/10.1186\/s13054-022-03913-5.","journal-title":"Crit Care"},{"issue":"16_suppl_2","key":"4400_CR3","doi-asserted-by":"publisher","first-page":"S366","DOI":"10.1161\/CIR.0000000000000916","volume":"142","author":"AR Panchal","year":"2020","unstructured":"Panchal AR, Bartos JA, Cabanas JG, Donnino MW, Drennan IR, Hirsch KG, et al. Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020;142(16_suppl_2):S366\u2013468. https:\/\/doi.org\/10.1161\/CIR.0000000000000916.","journal-title":"Circulation."},{"issue":"9","key":"4400_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00134-021-06481-4","volume":"47","author":"M Moseby-Knappe","year":"2021","unstructured":"Moseby-Knappe M, Mattsson-Carlgren N, Stammet P, Backman S, Blennow K, Dankiewicz J, et al. Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest. Intensive Care Med. 2021;47(9):984\u201394. https:\/\/doi.org\/10.1007\/s00134-021-06481-4.","journal-title":"Intensive Care Med"},{"issue":"10","key":"4400_CR5","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1007\/s00134-020-06080-9","volume":"46","author":"M Moseby-Knappe","year":"2020","unstructured":"Moseby-Knappe M, Westhall E, Backman S, Mattsson-Carlgren N, Dragancea I, Lybeck A, et al. Performance of a guideline-recommended algorithm for prognostication of poor neurological outcome after cardiac arrest. Intensive Care Med. 2020;46(10):1852\u201362. https:\/\/doi.org\/10.1007\/s00134-020-06080-9.","journal-title":"Intensive Care Med"},{"key":"4400_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.resuscitation.2018.11.007","volume":"134","author":"JH Kim","year":"2019","unstructured":"Kim JH, Kim MJ, You JS, Lee HS, Park YS, Park I, Chung SP. Multimodal approach for neurologic prognostication of out-of-hospital cardiac arrest patients undergoing targeted temperature management. Resuscitation. 2019;134:33\u201340. https:\/\/doi.org\/10.1016\/j.resuscitation.2018.11.007.","journal-title":"Resuscitation"},{"issue":"10","key":"4400_CR7","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00134-013-3004-y","volume":"39","author":"MJ Kamps","year":"2013","unstructured":"Kamps MJ, Horn J, Oddo M, Fugate JE, Storm C, Cronberg T, et al. Prognostication of neurologic outcome in cardiac arrest patients after mild therapeutic hypothermia: a meta-analysis of the current literature. Intensive Care Med. 2013;39(10):1671\u201382. https:\/\/doi.org\/10.1007\/s00134-013-3004-y.","journal-title":"Intensive Care Med"},{"issue":"01","key":"4400_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1055\/s-0036-1593858","volume":"37","author":"P Stammet","year":"2017","unstructured":"Stammet P. Blood biomarkers of hypoxic\u2013ischemic brain injury after cardiac arrest. Semin Neurol. 2017;37(01):75\u201380. https:\/\/doi.org\/10.1055\/s-0036-1593858.","journal-title":"Semin Neurol"},{"issue":"5","key":"4400_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ana.25067","volume":"82","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Zetterberg H, Nielsen N, Blennow K, Dankiewicz J, Friberg H, et al. Serum tau and neurological outcome in cardiac arrest. Ann Neurol. 2017;82(5):665\u201375. https:\/\/doi.org\/10.1002\/ana.25067.","journal-title":"Ann Neurol"},{"issue":"3","key":"4400_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.resuscitation.2012.07.027","volume":"84","author":"J Randall","year":"2013","unstructured":"Randall J. Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study. Resuscitation. 2013;84(3):351\u20136. https:\/\/doi.org\/10.1016\/j.resuscitation.2012.07.027.","journal-title":"Resuscitation"},{"key":"4400_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.resuscitation.2021.11.033","volume":"170","author":"J Humaloja","year":"2022","unstructured":"Humaloja J, Lahde M, Ashton NJ, Reinikainen M, Hastbacka J, Jakkula P, et al. GFAp and tau protein as predictors of neurological outcome after out-of-hospital cardiac arrest: a post hoc analysis of the COMACARE trial. Resuscitation. 2022;170:141\u20139. https:\/\/doi.org\/10.1016\/j.resuscitation.2021.11.033.","journal-title":"Resuscitation"},{"issue":"1","key":"4400_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jamaneurol.2018.3223","volume":"76","author":"M Moseby-Knappe","year":"2019","unstructured":"Moseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J, et al. Serum neurofilament light chain for prognosis of outcome after cardiac arrest. JAMA Neurol. 2019;76(1):64\u201371. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3223.","journal-title":"JAMA Neurol"},{"key":"4400_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/alz.045982","author":"LHT Dang","year":"2020","unstructured":"Dang LHT, Krinsky-McHale SJ, O\u2019Bryant S, Pang D, Zigman WB, Silverman W, et al. Elevated plasma neurofilament light (NfL) is associated with incident Alzheimer\u2019s disease and accelerated cognitive decline in adults with Down syndrome. Alzheimer\u2019s Dement. 2020. https:\/\/doi.org\/10.1002\/alz.045982.","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"4400_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41398-021-01563-9","volume":"11","author":"MA Beydoun","year":"2021","unstructured":"Beydoun MA, Noren Hooten N, Beydoun HA, Maldonado AI, Weiss J, Evans MK, et al. Plasma neurofilament light as a potential biomarker for cognitive decline in a longitudinal study of middle-aged urban adults. Transl Psychiatry. 2021;11(1):436. https:\/\/doi.org\/10.1038\/s41398-021-01563-9.","journal-title":"Transl Psychiatry"},{"issue":"8","key":"4400_CR15","doi-asserted-by":"publisher","first-page":"e0135886","DOI":"10.1371\/journal.pone.0135886","volume":"10","author":"M Vagberg","year":"2015","unstructured":"Vagberg M, Norgren N, Dring A, Lindqvist T, Birgander R, Zetterberg H, et al. Levels and age dependency of neurofilament light and glial fibrillary acidic protein in healthy individuals and their relation to the brain parenchymal fraction. PLoS ONE. 2015;10(8):e0135886. https:\/\/doi.org\/10.1371\/journal.pone.0135886.","journal-title":"PLoS ONE"},{"issue":"12","key":"4400_CR16","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.resuscitation.2014.09.007","volume":"85","author":"I-M Larsson","year":"2014","unstructured":"Larsson I-M. Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome. Resuscitation. 2014;85(12):1654\u201361. https:\/\/doi.org\/10.1016\/j.resuscitation.2014.09.007.","journal-title":"Resuscitation"},{"issue":"10","key":"4400_CR17","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1073\/pnas.1821282116","volume":"116","author":"H Liu","year":"2019","unstructured":"Liu H, Povysheva N, Rose ME, Mi Z, Banton JS, Li W, et al. Role of UCHL1 in axonal injury and functional recovery after cerebral ischemia. Proc Natl Acad Sci USA. 2019;116(10):4643\u201350. https:\/\/doi.org\/10.1073\/pnas.1821282116.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"4400_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/s1474-4422(18)30231-x","volume":"17","author":"JJ Bazarian","year":"2018","unstructured":"Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol. 2018;17(9):782\u20139. https:\/\/doi.org\/10.1016\/s1474-4422(18)30231-x.","journal-title":"Lancet Neurol"},{"issue":"16","key":"4400_CR19","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1042\/BCJ20160082","volume":"473","author":"P Bishop","year":"2016","unstructured":"Bishop P, Rocca D, Henley JM. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction. Biochem J. 2016;473(16):2453\u201362. https:\/\/doi.org\/10.1042\/BCJ20160082.","journal-title":"Biochem J"},{"key":"4400_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00134-020-06218-9","volume":"47","author":"L Wihersaari","year":"2021","unstructured":"Wihersaari L, Ashton NJ, Reinikainen M, et al. Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial. Intensive Care Med. 2021;47:39\u201348.","journal-title":"Intensive Care Med"},{"key":"4400_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.resuscitation.2020.05.016","volume":"154","author":"F Ebner","year":"2020","unstructured":"Ebner F, Moseby-Knappe M, Mattsson-Carlgren N, et al. Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients. Resuscitation. 2020;154:61\u20138.","journal-title":"Resuscitation"},{"key":"4400_CR22","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1445-5994.2006.01153.x","volume":"36","author":"DR Williams","year":"2006","unstructured":"Williams DR. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J. 2006;36:652\u201360.","journal-title":"Intern Med J."},{"issue":"14","key":"4400_CR23","doi-asserted-by":"publisher","first-page":"921809","DOI":"10.3389\/fnagi.2022.921809","volume":"7","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang H, Li L, Deng X, Bo L. Neurofilament light chain: a candidate biomarker of perioperative stroke. Front Aging Neurosci. 2022;7(14):921809.","journal-title":"Front Aging Neurosci"},{"key":"4400_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121\u201330.","journal-title":"Curr Opin Cell Biol"},{"key":"4400_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12028-016-0371-6","volume":"27","author":"K Helwig","year":"2017","unstructured":"Helwig K, Seeger F, H\u00f6lschermann H, Lischke V, Gerriets T, Niessner M, Foerch C. Elevated serum glial fibrillary acidic protein (GFAP) is associated with poor functional outcome after cardiopulmonary resuscitation. Neurocrit Care. 2017;27:68\u201374.","journal-title":"Neurocrit Care"},{"key":"4400_CR26","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.resuscitation.2009.04.003","volume":"80","author":"T Kaneko","year":"2009","unstructured":"Kaneko T, Kasaoka S, Miyauchi T, Fujita M, Oda Y, Tsuruta R, Maekawa T. Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation. 2009;80:790\u20134.","journal-title":"Resuscitation"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04400-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04400-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04400-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:44:29Z","timestamp":1684161869000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04400-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4400"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04400-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study included an informed consent form approved by all participating hospitals including the institutional review board (IRB) of Seoul St. Mary\u2019s Hospital (KC18TNSI0396). Written informed consent was obtained from all patients' legal surrogates.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has declared a conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}